Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Pulmonx Corporation

    NASDAQ: LUNG · Real-Time Price · USD
    3.16
    0.19 (6.40%)
    At close: Jun 06, 2025, 3:59 PM
    3.17
    0.32%
    After-hours: Jun 06, 2025, 04:04 PM EDT

    Pulmonx Statistics

    Share Statistics

    Pulmonx has 40.26M shares outstanding. The number of shares has increased by 2.53% in one year.

    Shares Outstanding

    n/a
    		 40.26M

    Shares Change (YoY)

    n/a
    		 2.53%

    Shares Change (QoQ)

    n/a
    		 0.78%

    Owned by Institutions (%)

    n/a
    		 91.33%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 53

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 1.56M, so 3.91% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.56M

    Short % of Shares Out

    n/a
    		 3.91%

    Short % of Float

    n/a
    		 5.52%

    Short Ratio (days to cover)

    n/a
    		 2.9

    Valuation Ratios

    The PE ratio is -4.71 and the forward PE ratio is -2.22. Pulmonx's PEG ratio is 0.47.

    PE Ratio

    n/a
    		 -4.71

    Forward PE

    n/a
    		 -2.22

    PS Ratio

    n/a
    		 3.17

    Forward PS

    n/a
    		 0.4

    PB Ratio

    n/a
    		 3.09

    P/FCF Ratio

    n/a
    		 -8.05

    PEG Ratio

    n/a
    		 0.47
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Pulmonx.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.58, with a Debt / Equity ratio of 0.66.

    Current Ratio

    n/a
    		 5.58

    Quick Ratio

    n/a
    		 4.88

    Debt / Equity

    n/a
    		 0.66

    Debt / EBITDA

    n/a
    		 -1.11

    Debt / FCF

    n/a
    		 -1.71

    Interest Coverage

    n/a
    		 -16.45

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $287,934.71

    Profits Per Employee

    n/a
    		 $-193,793.81

    Employee Count

    n/a
    		 291

    Asset Turnover

    n/a
    		 0.51

    Inventory Turnover

    n/a
    		 1.29

    Taxes

    Income Tax

    n/a
    		 500K

    Effective Tax Rate

    n/a
    		 -0.89%

    Stock Price Statistics

    The stock price has increased by -58.05% in the last 52 weeks. The beta is 0.52, so Pulmonx's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.52

    52-Week Price Change

    n/a
    		 -58.05%

    50-Day Moving Average

    n/a
    		 4.51

    200-Day Moving Average

    n/a
    		 6.38

    Relative Strength Index (RSI)

    n/a
    		 33.45

    Average Volume (20 Days)

    n/a
    		 359,336

    Income Statement

    In the last 12 months, Pulmonx had revenue of 83.79M and earned -56.39M in profits. Earnings per share was -1.44.

    Revenue

    n/a
    		 83.79M

    Gross Profit

    n/a
    		 62M

    Operating Income

    n/a
    		 -57.7M

    Net Income

    n/a
    		 -56.39M

    EBITDA

    n/a
    		 -50.79M

    EBIT

    n/a
    		 -52.39M

    Earnings Per Share (EPS)

    n/a
    		 -1.44
    Full Income Statement

    Balance Sheet

    The company has 70.91M in cash and 56.47M in debt, giving a net cash position of 14.43M.

    Cash & Cash Equivalents

    n/a
    		 70.91M

    Total Debt

    n/a
    		 56.47M

    Net Cash

    n/a
    		 14.43M

    Retained Earnings

    n/a
    		 -467.56M

    Total Assets

    n/a
    		 150.74M

    Working Capital

    n/a
    		 98.99M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -31.54M and capital expenditures -1.45M, giving a free cash flow of -32.98M.

    Operating Cash Flow

    n/a
    		 -31.54M

    Capital Expenditures

    n/a
    		 -1.45M

    Free Cash Flow

    n/a
    		 -32.98M

    FCF Per Share

    n/a
    		 -0.84
    Full Cash Flow Statement

    Margins

    Gross margin is 74%, with operating and profit margins of -68.87% and -67.3%.

    Gross Margin

    n/a
    		 74%

    Operating Margin

    n/a
    		 -68.87%

    Pretax Margin

    n/a
    		 -66.71%

    Profit Margin

    n/a
    		 -67.3%

    EBITDA Margin

    n/a
    		 -60.62%

    EBIT Margin

    n/a
    		 -68.87%

    FCF Margin

    n/a
    		 -39.37%

    Dividends & Yields

    LUNG does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for LUNG is $12, which is 304% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $12

    Price Target Difference

    n/a
    		 304%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 1.05

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist